Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bruker (BRKRP) EBT (2016 - 2025)

Bruker's EBT history spans 16 years, with the latest figure at $386.1 million for Q4 2025.

  • For Q4 2025, EBT rose 26.05% year-over-year to $386.1 million; the TTM value through Dec 2025 reached $339.9 million, down 25.64%, while the annual FY2025 figure was $339.9 million, 25.64% down from the prior year.
  • EBT reached $386.1 million in Q4 2025 per BRKRP's latest filing, up from -$71.8 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $386.1 million in Q4 2025 to a low of -$306.2 million in Q4 2022.
  • Average EBT over 5 years is $65.6 million, with a median of $78.8 million recorded in 2021.
  • Peak YoY movement for EBT: skyrocketed 531.85% in 2021, then crashed 229.84% in 2025.
  • A 5-year view of EBT shows it stood at -$289.5 million in 2021, then fell by 5.77% to -$306.2 million in 2022, then soared by 178.67% to $240.9 million in 2023, then increased by 27.15% to $306.3 million in 2024, then rose by 26.05% to $386.1 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's EBT are $386.1 million (Q4 2025), -$71.8 million (Q3 2025), and $500000.0 (Q2 2025).